SCHEMBL3655130

SCHEMBL3655130

O=S(=O)(c1ccc(Cl)c(Cl)c1)N1CCN(c2nc(Cc3cc(F)cc(Cl)c3)cs2)CC1.O=S(=O)(c1ccc(Cl)c(Cl)c1)N1CCN(c2nc(Cc3ccc(Cl)c(F)c3)cs2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HSD11B1 P28845 3/20 0.40
MAPT P10636 4/20 0.39
USP2 O75604 1/20 0.39
RECQL P46063 1/20 0.39
HSD17B10 Q99714 1/20 0.39
THRB P10828 1/20 0.39
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
LPAR1 Q92633 4/20 0.36
LPAR2 Q9HBW0 4/20 0.36
GBA1 P04062 1/20 0.36
LMNA P02545 2/20 0.35
POLB P06746 2/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3013972 0.95 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1L3MBTL1HSD11B1MAPT
SCHEMBL3002305 0.93 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1L3MBTL1HSD11B1MAPT
SCHEMBL3651758 0.92 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1L3MBTL1MAPTUSP2
SCHEMBL3008545 0.91 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1L3MBTL1HSD11B1MAPT
SCHEMBL3009001 0.90 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1L3MBTL1HSD11B1MAPT
SCHEMBL3009990 0.90 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1L3MBTL1HSD11B1MAPT
SCHEMBL3017633 0.90 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1L3MBTL1HSD11B1MAPT
SCHEMBL3652321 0.90 PKM (0.46) SMN1; SMN2ALDH1A1L3MBTL1HSD11B1MAPT
SCHEMBL3006932 0.89 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1L3MBTL1HSD11B1MAPT
SCHEMBL3008158 0.89 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1L3MBTL1HSD11B1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188272-A2 PHENYL- AND BENZYLTHIAZOLYLPIPERAZINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES NV Remynd (BE) 2010-05-26 EP disclosed
WO-2009019295-A2 PHENYL- AND BENZYLTHIAZOLYLPIPERAZINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES NV REMYND (BE) 2009-02-12 WO disclosed